Invesco Global Enhanced Equity UCITS ETF Acc is a equity ETF from Invesco tracking the Global Enhanced Equity index through physical replication. Domiciled in Ireland and launched in 2025, the fund manages about 855 M € and charges a TER of 0.24% — 24 € per year on a €10,000 investment. Income is automatically reinvested in the fund (accumulating).
Invesco Global Enhanced Equity UCITS ETF Acc competes with 261 other products in the same class and region (Equity, Developed markets): it ranks 89th by fund size and 88th by ongoing cost, with a TER of 0.24% against a group median of 0.26%. It has been listed since 2025, 1 years of track record.
On a €10,000 investment the TER costs 24 € a year, against 26 € for the median product in the category.
Replication is physical: the fund holds the underlying securities directly. The ten largest positions account for 27.0% of the portfolio.
Income is accumulated: no distribution is paid out, the share price absorbs it. In a savings plan this removes the need to reinvest dividends by hand. The fund is denominated in EUR. That is not the same as currency risk: the exposure comes from the currencies of the underlying holdings, not from the denomination or the trading currency of a given listing.
Irish domicile lets the fund apply the Ireland–US tax treaty, with 15% withholding instead of 30% on US dividends received by the fund.
| NVIDIA Corporation | 5.4% |
| Apple Inc. | 4.8% |
| Alphabet Inc Class A | 4.2% |
| Microsoft Corporation | 2.9% |
| Amazon.com Inc | 2.5% |
| Broadcom Inc | 1.8% |
| Micron Technology Inc | 1.7% |
| Meta Platforms Inc. | 1.4% |
| Tesla Inc | 1.3% |
| Advanced Micro Devices Inc | 1.0% |
| Borsa Italiana | IQGA | EUR |
| XETRA | IQGA | EUR |
| London Stock Exchange | IQGA | USD |
| London Stock Exchange | IQGX | GBX |
| SIX Swiss Exchange | IQGA | CHF |
Source: the fund's KID and the issuer's official documentation — data verified as of July 2026.
This page is informational and is not an investment recommendation. Figures may contain errors or be out of date: always check the KID and the issuer's factsheet before any decision.